Asthma is characterized by paroxysmaldyspnea,rales in the throat,difficulty in breathing,and inability to lie horizontally.It is commonly seenin children with a weak body constitution,and tendsto be intractable,thus b...Asthma is characterized by paroxysmaldyspnea,rales in the throat,difficulty in breathing,and inability to lie horizontally.It is commonly seenin children with a weak body constitution,and tendsto be intractable,thus being harmful to the展开更多
The therapeutic effect of Zhu Yu Hua Tan Tang (逐瘀化痰汤Decoction for removing blood stasis and resolving phlegm) plus general and modern treatment on acute cerebral hemorrhage in 44 cases, and the pressure-lowering ...The therapeutic effect of Zhu Yu Hua Tan Tang (逐瘀化痰汤Decoction for removing blood stasis and resolving phlegm) plus general and modern treatment on acute cerebral hemorrhage in 44 cases, and the pressure-lowering effect of Zhu Yu Hua Tan Tang and mannitol in 20 cases of acute cerebral hemorrhage in the basilar region, and in rabbits with experimental encephaledema induced by injection of olive oil into the common carotid artery were observed in this study. The results showed that Zhu Yu Hua Tan Tang plus general treatment can better improved the conscious state of the patients than western medicine, and it can make the intracranial pressure drop clinically by 40.44%. The intracranial pressure-lowering effect of Zhu Yu Hua Tan Tang, though slow, is smooth and long-lasting without any rebound phenomenon, as compared to those of mannitol. Similar results were found in animal experiments, but the intracranial pressure-lowering amplitude of Zhu Yu Hua Tan Tang was stronger than that of mannitol. The difference between the clinical and experimental results needs to be further studied.展开更多
目的观察针药并用治疗寻常型银屑病血瘀证的临床疗效及对患者皮损程度和摄食抑制因子-1(nesfatin-1)水平的影响。方法将80例寻常型银屑病患者随机分成中药组和针药组,每组40例。中药组采用活血化瘀汤治疗,针药组在中药组治疗基础上联合...目的观察针药并用治疗寻常型银屑病血瘀证的临床疗效及对患者皮损程度和摄食抑制因子-1(nesfatin-1)水平的影响。方法将80例寻常型银屑病患者随机分成中药组和针药组,每组40例。中药组采用活血化瘀汤治疗,针药组在中药组治疗基础上联合火针治疗。比较两组临床疗效,观察两组治疗前、治疗4周后和治疗后中医证候积分、银屑病皮损面积及严重度指数(psoriasis area and severity index,PASI)评分以及血清干扰素-γ(interferonγ,IFN-γ)和Nesfatin-1水平的变化。结果针药组总有效率为92.5%,明显高于中药组的75.0%(P<0.05)。两组中医证候积分和PASI评分均随治疗时间延长而逐渐降低(P<0.05),组间和时点存在交互作用(P<0.05);针药组治疗4周后及治疗后中医证候积分和PASI评分均明显低于中药组(P<0.05)。治疗后,两组血清IFN-γ水平均低于治疗前(P<0.05),血清Nesfatin-1水平均高于治疗前(P<0.05);且针药组上述血清指标均明显优于中药组(P<0.05)。结论火针联合活血化瘀汤治疗血瘀证寻常型银屑病的临床疗效优于单纯活血化瘀汤治疗,可改善临床症状和皮损,且可有效调节血清IFN-γ和Nesfatin-1水平。展开更多
文摘Asthma is characterized by paroxysmaldyspnea,rales in the throat,difficulty in breathing,and inability to lie horizontally.It is commonly seenin children with a weak body constitution,and tendsto be intractable,thus being harmful to the
文摘The therapeutic effect of Zhu Yu Hua Tan Tang (逐瘀化痰汤Decoction for removing blood stasis and resolving phlegm) plus general and modern treatment on acute cerebral hemorrhage in 44 cases, and the pressure-lowering effect of Zhu Yu Hua Tan Tang and mannitol in 20 cases of acute cerebral hemorrhage in the basilar region, and in rabbits with experimental encephaledema induced by injection of olive oil into the common carotid artery were observed in this study. The results showed that Zhu Yu Hua Tan Tang plus general treatment can better improved the conscious state of the patients than western medicine, and it can make the intracranial pressure drop clinically by 40.44%. The intracranial pressure-lowering effect of Zhu Yu Hua Tan Tang, though slow, is smooth and long-lasting without any rebound phenomenon, as compared to those of mannitol. Similar results were found in animal experiments, but the intracranial pressure-lowering amplitude of Zhu Yu Hua Tan Tang was stronger than that of mannitol. The difference between the clinical and experimental results needs to be further studied.
文摘目的观察针药并用治疗寻常型银屑病血瘀证的临床疗效及对患者皮损程度和摄食抑制因子-1(nesfatin-1)水平的影响。方法将80例寻常型银屑病患者随机分成中药组和针药组,每组40例。中药组采用活血化瘀汤治疗,针药组在中药组治疗基础上联合火针治疗。比较两组临床疗效,观察两组治疗前、治疗4周后和治疗后中医证候积分、银屑病皮损面积及严重度指数(psoriasis area and severity index,PASI)评分以及血清干扰素-γ(interferonγ,IFN-γ)和Nesfatin-1水平的变化。结果针药组总有效率为92.5%,明显高于中药组的75.0%(P<0.05)。两组中医证候积分和PASI评分均随治疗时间延长而逐渐降低(P<0.05),组间和时点存在交互作用(P<0.05);针药组治疗4周后及治疗后中医证候积分和PASI评分均明显低于中药组(P<0.05)。治疗后,两组血清IFN-γ水平均低于治疗前(P<0.05),血清Nesfatin-1水平均高于治疗前(P<0.05);且针药组上述血清指标均明显优于中药组(P<0.05)。结论火针联合活血化瘀汤治疗血瘀证寻常型银屑病的临床疗效优于单纯活血化瘀汤治疗,可改善临床症状和皮损,且可有效调节血清IFN-γ和Nesfatin-1水平。
